Associate Director, Oncology Clinical Sciences - Hybrid

Moderna; Bethesda (MD); Hybrid; USD 159,000 - 286,000; Full time

Benefits offered by this job

Competitive healthcare

Well-being resources

Family planning benefits

Generous paid time off

Retirement savings

Job summary

Moderna is seeking a senior clinical trial professional to support Oncology programs, working with the Clinical Study Lead to develop, execute and evaluate Phase 1–3 studies. You will ensure high-quality data for governance and regulatory submissions, collaborating across operations and safety domains.

The role emphasizes end-to-end trial delivery, data review, and timely reporting while participating in Investigator Meetings and regulatory content development.

Qualifications

• PhD/PharmD/Masters or advanced nursing degree with oncology knowledge and pharma/biotech experience.
• Minimum of 8 years of clinical development experience in pharma/biotech.
• Experience ensuring clinical trial data integrity and data analysis; familiarity with Medidata Rave, Elluminate, Spotfire.

Responsibilities

• Oversee end-to-end delivery of clinical trial protocols with study design, initiation and closeout activities.
• Review and interpret clinical data and ensure timely deliverables with Trial Team and external partners.
• Support study sites to ensure safety decisions align with protocol and guide Investigator Meetings.

Skills

Data analysis

Data integrity

Teamwork

Communication

Travel readiness

Education

PhD / PharmD / Masters or advanced nursing degree

Tools

Medidata Rave

Elluminate

Spotfire

Job description

Moderna is seeking a senior clinical trial professional to support Oncology programs, working with the Clinical Study Lead to develop, execute and evaluate Phase 1–3 studies. You will ensure high-quality data for governance and regulatory submissions, collaborating across operations and safety domains.

The role emphasizes end-to-end trial delivery, data review, and timely reporting while participating in Investigator Meetings and regulatory content development.